Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Lung cancer

See realtime coverage

Melbourne researchers uncover breakthrough lung cancer drug

Ten Eyewitness News - ‎5 hours ago‎
There's new hope for lung cancer suffers and those at risk of developing the disease. Melbourne researchers have discovered a breakthrough new drug that ...

Breakthrough lung cancer drug discovery by Melbourne researchers ...

Herald Sun - ‎18 hours ago‎
A BREAKTHROUGH discovery has opened up a potential new drug to stop lung cancer and emphysema as well as detecting the killer diseases much sooner.

Lung cancer treatment offered at RWJUH Somerset - ‎9 hours ago‎
Justin Perry's stage four lung cancer isn't stopping him from marrying the woman he loves. He proposed at Fenway Park and Michelle White said yes.
See realtime coverage

AbbVie and Bristol-Myers Squibb to collaborate on lung cancer clinical trial

MarketWatch - ‎20 hours ago‎
AbbVie Inc. ABBV, +0.80% and Bristol-Myers Squibb Company BMY, -0.16% said Monday morning they will collaborate on a clinical trial for a lung cancer treatment combining AbbVie's Rova-T with Bristol-Myers Squibb's Opdivo and an Opdivo + Yervoy ...

Epidemiology of Lung Cancer - ‎3 hours ago‎
The incidence of lung cancer in the 20th century has largely mirrored the rise and fall in cigarette smoking. The risk of lung cancer in smokers is ten times that of non-smokers. However, the incidence is expected to plateau in the next few decades ...

Lymph Nodes in Lung Cancer - ‎2 hours ago‎
Evaluation of the hilar and mediastinal lymph nodes is part of the surgical treatment of non-small cell lung cancer (NSCLC).
See realtime coverage

China plans to treat lung-cancer patients with genetic modification

RedOrbit - ‎14 hours ago‎
Chinese researchers have announced their intention to treat lung-cancer patients with cells that have been modified using CRISPR/Cas9 gene-editing method, which would mark the first time that the controversial technique had been used to alter the DNA ...

Breakthrough lung cancer drug must be available on NHS, AstraZeneca says - ‎Jul 20, 2016‎
A breakthrough lung cancer drug developed by UK scientists, which passed final clinical trials this week, might not be available on the NHS because it has been deemed too expensive by the drugs watchdog, it has emerged.

Take Our Quiz - Check your Lung Cancer IQ | La Crosse – WKBT ... - WKBT - ‎13 hours ago‎
1. True or False. Lung screening is a test to look for signs of lung cancer in otherwise healthy people. 2. Which of the following people have the greatest risk of ...
See realtime coverage

Chinese Scientists Look to Cure Lung Cancer With Genetic ... - ‎9 hours ago‎
There is a new tool in the biotechnology tool belt that may revolutionize the way medicine treats a host of diseases. It is called CRISPR-Cas9.
See realtime coverage

New therapeutic targets for small cell lung cancer identified

Science Daily - ‎Jul 21, 2016‎
"We used a genetically engineered mouse model that develops human-like small cell lung cancer and identified two regulatory pathways that in turn revealed vulnerabilities in this cancer," said senior author Dr.

Lung cancer looms over Helwan residents amid increased factory pollution: Maat

Daily News Egypt - ‎17 hours ago‎
Lung cancer has become a common cause of death for workers and citizens who live near industrial facilities in Helwan,” Shentenawy said, referring to official death certificates of citizens documented in recent months by the local health unit.
See realtime coverage

Tagrisso Slows Progression in Non-Small Cell Lung Cancer Subset - ‎15 hours ago‎
Tagrisso (osimertinib) showed benefit for patients with EGFR T790M-mutant locally-advanced or metastatic non–small cell lung cancer (NSCLC) who progressed on a frontline EGFR TKI. Results were first seen in a phase 2 study, then confirmed in the phase ...
See realtime coverage

AstraZeneca wants to advance lung cancer drug after hitting PhIII target

FierceBiotech - ‎Jul 18, 2016‎
One of AstraZeneca's ($AZN) key drugs for its ambitious sales target Tagrisso (osimertinib) has hit its marks in a Phase III test for certain lung cancer patients--passing a key FDA confirmatory study request. The Anglo-Swedish Big Pharma said its ...

Lung Cancer or Mesothelioma? BAP1 May be Key

Surviving Mesothelioma - ‎12 hours ago‎
While lung carcinoma and pleural mesothelioma are both malignancies, mesothelioma can grow and spread differently and may respond better to different types of treatment than lung carcinoma. Unfortunately, the two cancers can be difficult to ...

The Connection between Lung Cancer and Outdoor Air Pollution - ‎Jul 21, 2016‎
Lung cancer is the #1 cancer killer of both men and women in the U.S. When you think of risk factors for lung cancer, what comes to mind? Most of us think about the risk associated with smoking cigarettes, but did you know that air pollution can also ...
See realtime coverage

Public Health England millions of people may be living with lung cancer without knowing it

Daily Mail - ‎Jul 14, 2016‎
Millions of people may be ignoring the symptoms of lung cancer or heart disease, Public Health England has warned. The watchdog said anyone with an ongoing cough or who gets out of breath more easily should visit their GP as soon as possible.

In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October

Motley Fool - ‎Jul 23, 2016‎
On the other end of the spectrum are diseases like pancreatic cancer and lung/bronchus cancer, which have much lower five-year survival rates.

Upfront Immunotherapy for Lung Cancer? Not Yet

Medscape - ‎Jul 14, 2016‎
Immune checkpoint inhibitors have dramatically changed the treatment landscape of advanced non-small cell lung cancer (NSCLC), says Justin F. Gainor, MD, from Massachusetts General Hospital Cancer Center in Boston, in an editorial published online ...

New York researchers testing lung cancer vaccine

CCTV-America - ‎Jul 18, 2016‎
The U.S. is on the verge of testing a promising lung cancer vaccine from Cuba, one that also has the potential to fight a wide range of other cancers.